T.P.46 A novel phase 2a study design to investigate drug-drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha-glucosidase in subjects with Pompe disease Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kishnani, P
  • Tarnopolsky, Mark
  • Sivakumar, K
  • Byrne, B
  • Goker-Alpan, O
  • Guter, K
  • Pervaiz, M
  • Dasouki, M
  • Levine, T
  • Roberts, M
  • Johnson, FK
  • Valenzano, KJ
  • Lockhart, DJ
  • Boudes, P

publication date

  • October 2012